Key players in the Central Mass. life science ecosystem are taking on a new initiative to help launch Worcester to the forefront of bioindustrial manufacturing.
A UMass Chan Medical School research initiative has received $600,000 in funding from National Institute of Justice to investigate the prison classification system through an equity lens.
UMass Memorial Medical Group and UMass Memorial Medical Center in Worcester have initiated a lawsuit against St. Elizabeth’s Medical Center of Boston, part of Steward Health Care System, for nonpayment of services.
The five-school University of Massachusetts system generated $8.3 billion for the Massachusetts economy in 2022, according to a Thursday report from the university.
Mustang Bio, a clinical-stage biopharmaceutical company headquartered in Worcester, has received clearance from the U.S. Food and Drug Administration to enter into clinical trials for a drug to treat glioblastoma, a highly aggressive form of brain cancer.
Boston Scientific, a Marlborough-based biomedical life sciences firm, is using electronic health records from 80 million U.S. patients to inform a new study into pulmonary embolism.
Saint Vincent Hospital in Worcester is relaunching its volunteer program, which has been closed since shortly after the start of the COVID-19 pandemic.
About 76,000 people have been removed from the MassHealth rolls since March, and officials continue to forecast the biggest impacts are around the corner as a massive reevaluation of eligibility ramps up this fall.
Southborough-based clinical research organization Veristat has acquired a New Jersey CRO, Instat Clinical Research, adding new abilities to transform data to its portfolio.